How are PSCH strangle max profit and max loss calculated?

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the PSCH strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 33.90%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$123.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a PSCH strangle?

The breakeven for the PSCH strangle priced on this page is roughly $48.77 and $56.23 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current PSCH market-implied 1-standard-deviation expected move is approximately 9.72%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current PSCH implied volatility affect this strangle?

PSCH ATM IV is at 33.90% with IV rank near 33.91%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

PSCH Strangle Strategy

PSCH (Invesco S&P SmallCap Health Care ETF), in the Financial Services sector, (Asset Management industry), listed on NASDAQ.

Invesco Exchange-Traded Fund Trust II - Invesco S&P SmallCap Health Care ETF is an exchange traded fund launched and managed by Invesco Capital Management LLC. It invests in public equity markets of the United States. It invests in stocks of companies operating across health care sectors. It invests in growth and value stocks of small-cap companies. It seeks to track the performance of the S&P SmallCap 600 Capped Health Care Index, by using full replication technique. Invesco Exchange-Traded Fund Trust II - Invesco S&P SmallCap Health Care ETF was formed on April 7, 2010 and is domiciled in the United States.

PSCH (Invesco S&P SmallCap Health Care ETF) trades in the Financial Services sector, specifically Asset Management, with a market capitalization of approximately $181.4M, a beta of 1.04 versus the broader market, a 52-week range of 37.45-52.6, average daily share volume of 17K, a public-listing history dating back to 2010. These structural characteristics shape how PSCH etf options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.04 places PSCH roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. PSCH pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.

What is a strangle on PSCH?

A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.

Current PSCH snapshot

As of June 30, 2026, spot at $52.38, ATM IV 33.90%, IV rank 33.91%, expected move 9.72%. The strangle on PSCH below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.

Why this strangle structure on PSCH specifically: PSCH IV at 33.90% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 9.72% (roughly $5.09 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated PSCH expiries trade a higher absolute premium for lower per-day decay. Position sizing on PSCH should anchor to the underlying notional of $52.38 per share and to the trader's directional view on PSCH etf.

PSCH strangle setup

The PSCH strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With PSCH near $52.38, the first option leg uses a $55.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed PSCH chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 PSCH shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$55.00	$0.63
Buy 1	Put	$50.00	$0.60

PSCH strangle risk and reward

Net Premium / Debit: -$123.00
Max Profit (per contract): Unbounded
Max Loss (per contract): -$123.00
Breakeven(s): $48.77, $56.23
Risk / Reward Ratio: Unbounded

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.

PSCH strangle payoff curve

Modeled P&L at expiration across a range of underlying prices for the strangle on PSCH. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	+$4,876.00
$11.59	-77.9%	+$3,717.96
$23.17	-55.8%	+$2,559.92
$34.75	-33.7%	+$1,401.88
$46.33	-11.5%	+$243.84
$57.91	+10.6%	+$168.20
$69.49	+32.7%	+$1,326.24
$81.07	+54.8%	+$2,484.28
$92.65	+76.9%	+$3,642.32
$104.23	+99.0%	+$4,800.36

When traders use strangle on PSCH

Strangles on PSCH are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the PSCH chain.

PSCH thesis for this strangle

The market-implied 1-standard-deviation range for PSCH extends from approximately $47.29 on the downside to $57.47 on the upside. A PSCH long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current PSCH IV rank near 33.91% is mid-range against its 1-year distribution, so the IV signal is neutral; the strangle thesis on PSCH should anchor more to the directional view and the expected-move geometry. As a Financial Services name, PSCH options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to PSCH-specific events.

PSCH strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. PSCH positions also carry Financial Services sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move PSCH alongside the broader basket even when PSCH-specific fundamentals are unchanged. Always rebuild the position from current PSCH chain quotes before placing a trade.

Frequently asked questions

What is a strangle on PSCH?: A strangle on PSCH is the strangle strategy applied to PSCH (etf). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With PSCH etf trading near $52.38, the strikes shown on this page are snapped to the nearest listed PSCH chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are PSCH strangle max profit and max loss calculated?: Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the PSCH strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 33.90%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$123.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a PSCH strangle?: The breakeven for the PSCH strangle priced on this page is roughly $48.77 and $56.23 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current PSCH market-implied 1-standard-deviation expected move is approximately 9.72%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a strangle on PSCH?: Strangles on PSCH are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the PSCH chain.
How does current PSCH implied volatility affect this strangle?: PSCH ATM IV is at 33.90% with IV rank near 33.91%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.